Opioids Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2022 - 2030
- Report ID: GVR-2-68038-131-3
- Number of Pages: 120
- Format: Electronic (PDF)
- Historical Range: 2018 - 2020
- Industry:Healthcare
Market segmentation
- OpioidsProductOutlook (Revenue, USD Million; 2018 - 2030)
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- OpioidsApplicationOutlook (Revenue, USD Million; 2018 - 2030)
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- OpioidsRoute of AdministrationOutlook (Revenue, USD Million; 2018 - 2030)
- Oral
- Injectable
- Others
- OpioidsDistribution ChannelOutlook (Revenue, USD Million; 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Opioids Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- North America Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- North America Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- North America Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- U.S.
- U.S. Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- U.S. Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- U.S. Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- U.S. Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- U.S. Opioids Market, by Product
- Canada
- Canada Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Canada Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Canada Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Canada Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Canada Opioids Market, by Product
- North America Opioids Market, by Product
- Europe
- 欧洲Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- 欧洲Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- 欧洲Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- 欧洲Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- UK
- UK Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- UK Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- UK Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- UK Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- UK Opioids Market, by Product
- Germany
- Germany Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Germany Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Germany Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Germany Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Germany Opioids Market, by Product
- France
- France Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- France Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- France Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- France Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- France Opioids Market, by Product
- Italy
- Italy Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Italy Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Italy Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Italy Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Italy Opioids Market, by Product
- Spain
- Spain Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Spain Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Spain Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Spain Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Spain Opioids Market, by Product
- Asia Pacific
- Asia Pacific Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Asia Pacific Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Asia Pacific Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Asia Pacific Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Japan
- Japan Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Japan Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Japan Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Japan Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Japan Opioids Market, by Product
- China
- China Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- China Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- China Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- China Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- China Opioids Market, by Product
- India
- 印度阿片类药物市场,通过产品
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- India Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- India Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- India Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- 印度阿片类药物市场,通过产品
- Australia
- Australia Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Australia Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Australia Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Australia Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Australia Opioids Market, by Product
- South Korea
- South Korea Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- South Korea Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- South Korea Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- South Korea Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- South Korea Opioids Market, by Product
- Asia Pacific Opioids Market, by Product
- Latin America
- Latin America Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Latin America Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Latin America Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Latin America Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Brazil
- Brazil Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Brazil Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Brazil Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Brazil Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Brazil Opioids Market, by Product
- Mexico
- Mexico Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- 墨西哥阿片类药物市场,通过应用程序
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Mexico Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Mexico Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Mexico Opioids Market, by Product
- Argentina
- Argentina Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Argentina Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Argentina Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Argentina Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Argentina Opioids Market, by Product
- Latin America Opioids Market, by Product
- MEA
- MEA Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- MEA Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- MEA Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- MEA Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- South Africa
- 南非开始钟声ids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- 南非开始钟声ids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- 南非开始钟声ids Market, by Route of Administration
- Oral
- Injectable
- Others
- 南非开始钟声ids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- 南非开始钟声ids Market, by Product
- Saudi Arabia
- Saudi Arabia Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- Saudi Arabia Opioids Market, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhoea Suppression
- De-addiction
- Saudi Arabia Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- Saudi Arabia Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- Saudi Arabia Opioids Market, by Product
- UAE
- UAE Opioids Market, by Product
- IR/ Short Acting Opioids
- Immediate-Release/Short-Acting Opioid, by Product
- Codeine
- Oxycodone
- Hydrocodone
- Fentanyl
- Morphine
- Hydroxymorphone
- Oxymorphone
- Propoxyphene
- Other IR
- Immediate-Release/Short-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Immediate-Release/Short-Acting Opioid, by Product
- ER/Long Acting Opioids
- Extended-Release/Long-Acting Opioid, by Product
- Oxycodone
- Hydrocodone
- Methadone
- Fentanyl
- Morphine
- Oxymorphone
- Tapentadol
- Buprenorphine
- Hydromorphone
- Other ER
- Extended-Release/Long-Acting Opioid, by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- De-addiction
- Extended-Release/Long-Acting Opioid, by Product
- IR/ Short Acting Opioids
- UAE Opioids Market, by Application
- Pain relief
- Anesthesia
- Cough Suppression
- Diarrhoea suppression
- De-addiction
- UAE Opioids Market, by Route of Administration
- Oral
- Injectable
- Others
- UAE Opioids Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
- UAE Opioids Market, by Product
- MEA Opioids Market, by Product
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- 乐鱼体育手机网站入口
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report -free of charge——包括购买单独的部分或计谋ntry-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us nowto get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.
